These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. 2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: Design, synthesis, cell growth and tubulin polymerization inhibition. Romagnoli R, Kimatrai Salvador M, Schiaffino Ortega S, Baraldi PG, Oliva P, Baraldi S, Lopez-Cara LC, Brancale A, Ferla S, Hamel E, Balzarini J, Liekens S, Mattiuzzo E, Basso G, Viola G. Eur J Med Chem; 2018 Jan 01; 143():683-698. PubMed ID: 29220790 [Abstract] [Full Text] [Related]
7. Design, synthesis, and biological evaluation of novel combretastatin A-4 thio derivatives as microtubule targeting agents. Stefański T, Mikstacka R, Kurczab R, Dutkiewicz Z, Kucińska M, Murias M, Zielińska-Przyjemska M, Cichocki M, Teubert A, Kaczmarek M, Hogendorf A, Sobiak S. Eur J Med Chem; 2018 Jan 20; 144():797-816. PubMed ID: 29291446 [Abstract] [Full Text] [Related]
15. Design, Synthesis, and Evaluation of in Vitro and in Vivo Anticancer Activity of 4-Substituted Coumarins: A Novel Class of Potent Tubulin Polymerization Inhibitors. Cao D, Liu Y, Yan W, Wang C, Bai P, Wang T, Tang M, Wang X, Yang Z, Ma B, Ma L, Lei L, Wang F, Xu B, Zhou Y, Yang T, Chen L. J Med Chem; 2016 Jun 23; 59(12):5721-39. PubMed ID: 27213819 [Abstract] [Full Text] [Related]
16. Evaluation of 4-phenylamino-substituted naphthalene-1,2-diones as tubulin polymerization inhibitors. Yang H, An B, Li X, Zeng W. Bioorg Med Chem Lett; 2018 Oct 01; 28(18):3057-3063. PubMed ID: 30093295 [Abstract] [Full Text] [Related]
17. Synthesis, in vitro and in vivo evaluation of new hybrids of millepachine and phenstatin as potent tubulin polymerization inhibitors. An B, Zhang S, Yan J, Huang L, Li X. Org Biomol Chem; 2017 Jan 25; 15(4):852-862. PubMed ID: 28009925 [Abstract] [Full Text] [Related]
18. Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents. Wang G, Li C, He L, Lei K, Wang F, Pu Y, Yang Z, Cao D, Ma L, Chen J, Sang Y, Liang X, Xiang M, Peng A, Wei Y, Chen L. Bioorg Med Chem; 2014 Apr 01; 22(7):2060-79. PubMed ID: 24629450 [Abstract] [Full Text] [Related]
19. Synthesis and evaluation of new 2-chloro-4-aminopyrimidine and 2,6-dimethyl-4-aminopyrimidine derivatives as tubulin polymerization inhibitors. Xu S, An B, Li Y, Luo X, Li X, Jia X. Bioorg Med Chem Lett; 2018 Jun 01; 28(10):1769-1775. PubMed ID: 29673981 [Abstract] [Full Text] [Related]
20. Discovery of 3-(((9H-purin-6-yl)amino)methyl)-4,6-dimethylpyridin-2(1H)-one derivatives as novel tubulin polymerization inhibitors for treatment of cancer. Zhang Q, Hu X, Wan G, Wang J, Li L, Wu X, Liu Z, Yu L. Eur J Med Chem; 2019 Dec 15; 184():111728. PubMed ID: 31610375 [Abstract] [Full Text] [Related] Page: [Next] [New Search]